Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILITI, INC.

(AGTI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Managing Modest Gains

09/14/2021 | 01:00pm EDT


ę MT Newswires 2021
All news about AGILITI, INC.
10/20Certain Common Stock of Agiliti, Inc. are subject to a Lock-Up Agreement Ending on 20-O..
CI
10/20Certain Stock Options of Agiliti, Inc. are subject to a Lock-Up Agreement Ending on 20-..
CI
10/20Certain Restricted STock Units of Agiliti, Inc. are subject to a Lock-Up Agreement End..
CI
10/19AGILITI : Announces Third Quarter 2021 Earnings Release Date and Conference Call
BU
10/04AGILITI : ​AGILITI COMPLETES THE ACQUISITION OF SIZEWISE (Form 8-K)
PU
10/04AGILITI, INC. DE : Entry into a Material Definitive Agreement, Creation of a Direct Financ..
AQ
10/04AGILITI : Completes the Acquisition of Sizewise
BU
10/01Agiliti, Inc. completed the acquisition of Sizewise Rentals, LLC.
CI
09/20AGILITI, INC.(NYSE : AGTI) added to S&P Health Care Services Select Industry Index
CI
09/20AGILITI, INC.(NYSE : AGTI) added to S&P Global BMI Index
CI
More news
Analyst Recommendations on AGILITI, INC.
More recommendations
Financials (USD)
Sales 2021 1 016 M - -
Net income 2021 13,7 M - -
Net Debt 2021 938 M - -
P/E ratio 2021 256x
Yield 2021 0,01%
Capitalization 2 999 M 2 999 M -
EV / Sales 2021 3,88x
EV / Sales 2022 3,26x
Nbr of Employees 3 900
Free-Float 98,9%
Chart AGILITI, INC.
Duration : Period :
Agiliti, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AGILITI, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 23,00 $
Average target price 25,00 $
Spread / Average Target 8,70%
EPS Revisions
Managers and Directors
Thomas J. Leonard Chief Executive Officer & Director
Thomas W. Boehning President
James B. Pekarek Chief Financial Officer & Executive Vice President
John L. Workman Non-Executive Chairman
Michael A. Bell Independent Director
Sector and Competitors
1st jan.Capi. (M$)
AGILITI, INC.0.00%2 999
ABBOTT LABORATORIES17.02%224 403
MEDTRONIC PLC5.90%166 288
BECTON, DICKINSON AND COMPANY-1.55%70 767
HOYA CORPORATION21.09%55 682
DEXCOM, INC.52.99%54 986